Task: Answer the multiple-choice question.
Question: Which drug exhibits a 11.024% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CCOc1ccc(C(C(=O)NCC2CCCO2)N(C(=O)c2snc(C(N)=O)c2N)c2cccc(F)c2)cc1
b.) COC(=O)[C@H](CCSC)NC(=O)Nc1cc(C)ccc1C
c.) O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1N1CCN(c2ccccn2)CC1
d.) CCCCOC(=O)c1ccc(NC(=O)C(=O)NCc2cccnc2)cc1
e.) C=CCn1c(SCC(=O)NC2CCCC2)nnc1-c1ccncc1
Answer: b. COC(=O)[C@H](CCSC)NC(=O)Nc1cc(C)ccc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)[C@H](CCSC)NC(=O)Nc1cc(C)ccc1C
COC(=O)[C@H](CCSC)NC(=O)Nc1cc(C)ccc1C
methyl (2S)-2-[(2,5-dimethylphenyl)carbamoylamino]-4-methylsulfanylbutanoate